Heron Patrick J bought MIRM
January 23, 2026 · Form 4 insider transaction
Heron Patrick J bought 159,277 shares of Mirum Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
Frazier Life Sciences X, L.P. received these shares in connection with merger of Bluejay Therapeutics, Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the closing price of the Issuer's Common Stock was $94.29 per share.; The shares are held directly by Frazier Life Sciences X, L.P. FHMLS X, L.P. is the general partner of Frazier Life Sciences X, L.P. and FHMLS X, L.L.C. is the general partner of FHMLS X, L.P. The Reporting Person is one of two managing members of FHMLS X, L.L.C. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.